Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
29 mars 2019 09h00 HE
|
Generex Biotechnology Corp.
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL,...